Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Aiello

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Investigation|November 1, 1996
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growthP Xia, L P Aiello, H Ishii, et al.
Diabetes Care|December 13, 2022
Retinopathy During the First 5 Years of Type 1 Diabetes and Subsequent Risk of Advanced RetinopathyJohn I Malone, Xiaoyu Gao, Gayle M Lorenzi, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 11, 2009
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema, Roy W Beck, Allison R Edwards, et al.
The Journal of Clinical Investigation|October 1, 1995
Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissueY Nishio, C E Warren, J A Buczek-Thomas, et al.
The New England Journal of Medicine|December 1, 1994
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersL P Aiello, R L Avery, P G Arrigg, et al.
Diabetes|September 1, 1997
Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitorL P Aiello, S E Bursell, A Clermont, et al.
Ophthalmology|September 13, 2005
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edemaEmmett T Cunningham, Anthony P Adamis, Michael Altaweel, et al.
Ophthalmology|June 5, 2007
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study, E Chew, S Strauber, et al.
The Journal of Clinical Investigation|August 23, 2000
Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factorY Hata, A Clermont, T Yamauchi, et al.
Retina (Philadelphia, Pa.)|May 17, 2014
Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetesPaolo S Silva, Prisca A Diala, Rola N Hamam, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Investigation|November 1, 1996
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growthP Xia, L P Aiello, H Ishii, et al.
Diabetes Care|December 13, 2022
Retinopathy During the First 5 Years of Type 1 Diabetes and Subsequent Risk of Advanced RetinopathyJohn I Malone, Xiaoyu Gao, Gayle M Lorenzi, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 11, 2009
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema, Roy W Beck, Allison R Edwards, et al.
The Journal of Clinical Investigation|October 1, 1995
Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissueY Nishio, C E Warren, J A Buczek-Thomas, et al.
The New England Journal of Medicine|December 1, 1994
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersL P Aiello, R L Avery, P G Arrigg, et al.
Diabetes|September 1, 1997
Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitorL P Aiello, S E Bursell, A Clermont, et al.
Ophthalmology|September 13, 2005
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edemaEmmett T Cunningham, Anthony P Adamis, Michael Altaweel, et al.
Ophthalmology|June 5, 2007
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study, E Chew, S Strauber, et al.
The Journal of Clinical Investigation|August 23, 2000
Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factorY Hata, A Clermont, T Yamauchi, et al.
Retina (Philadelphia, Pa.)|May 17, 2014
Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetesPaolo S Silva, Prisca A Diala, Rola N Hamam, et al.
Pageof 13